Yin-Yang regulation of RORγt protein complex in Th17 differentiation

International Reviews of Immunology

Volumn 34, Issue 4, 2015, Pages 295-304

  Gao, Weiwu ^a   Wu, Yuzhang ^a   Tian, Yi ^a   Ni, Bing ^a  

^a THIRD MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

Protein protein interaction; ROR t; Th17 cells; Transcription factor

Indexed keywords

DIGOXIN; INTERFERON CONSENSUS SEQUENCE BINDING PROTEIN; INTERFERON REGULATORY FACTOR 4; INTERLEUKIN 17; RETINOID RELATED ORPHAN RECEPTOR GAMMA; SMAD2 PROTEIN; SMAD3 PROTEIN; TRANSCRIPTION FACTOR FOXP3; TRANSCRIPTION FACTOR RUNX1; MULTIPROTEIN COMPLEX;

CELL DIFFERENTIATION; COMPLEX FORMATION; CYTOKINE PRODUCTION; HUMAN; IMMUNE SYSTEM; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; REGULATORY MECHANISM; REVIEW; TH17 CELL; ANIMAL; CELL LINEAGE; CHINESE MEDICINE; GENETICS; IMMUNOLOGY; INFLAMMATION; METABOLISM;

ANIMALS; CELL DIFFERENTIATION; CELL LINEAGE; HUMANS; INFLAMMATION; MULTIPROTEIN COMPLEXES; NUCLEAR RECEPTOR SUBFAMILY 1, GROUP F, MEMBER 3; TH17 CELLS; YIN-YANG;

EID: 84953874292     PISSN: 08830185     EISSN: 15635244     Source Type: Journal    
DOI: 10.3109/08830185.2014.969423     Document Type: Review

References (71)

1. Steinman L. A brief history of T(H)17, the first major revision in the T(H)1/T(H)2 hypothesis of T cell-mediated tissue damage. NatMed 2007; 13(2): 139-145.
2. Ciofani M, Madar A, Galan C, et al. A validated regulatory network forTh17 cell specification. Cell 2012; 151(2): 289-303.
3. Szabo SJ,Kim ST,Costa GL, et al.Anovel transcription factor, T-bet, directsTh1 lineage commitment. Cell 2000; 100(6): 655-669.
4. Zheng W, Flavell RA. The transcription factor GATA-3 is necessary and sufficient for Th2 cytokine gene expression in CD4 T cells. Cell 1997; 89(4): 587-596.
5. Hori S, Nomura T, Sakaguchi S. Control of regulatory T cell development by the transcription factor Foxp3. Science 2003; 299(5609): 1057-1061.
6. Nurieva RI, Chung Y, Martinez GJ, et al. Bcl6 mediates the development of T follicular helper cells. Science 2009; 325(5943): 1001-1005.
7. Park H, Li Z, Yang XO, et al. A distinct lineage of CD4 T cells regulates tissue inflammation by producing interleukin 17. Nat Immunol; 6(11): 1133-1141.
8. Harrington LE,Hatton RD,Mangan PR, et al. Interleukin 17-producing CD4+effector T cells develop via a lineage distinct from the T helper type 1 and 2 lineages. Nat Immunol 2005; 6(11): 1123-1132.
9. Korn T, Bettelli E, Gao W, et al. IL-21 initiates an alternative pathway to induce proinflammatory T(H)17 cells. Nature 2007; 448(7152): 484-487.
10. Ouyang W, Kolls JK, Zheng Y.Thebiological functions of T helper 17 cell effector cytokines in inflammation. Immunity 2008; 28(4): 454-467.
11. Ivanov, II, McKenzie BS, Zhou L, et al.The orphan nuclear receptor RORgammat directs the differentiation program of proinflammatory IL-17+ T helper cells. Cell 2006; 126(6): 1121-1133.
12. Manel N, Unutmaz D, Littman DR. The differentiation of human T(H)-17 cells requires transforming growth factor-beta and induction of the nuclear receptor RORgammat. Nat Immunol 2008; 9(6): 641-649.
13. Sundrud MS, Rao A. Regulation of T helper 17 differentiation by orphan nuclear receptors: It's not just ROR gamma t anymore. Immunity 2008; 28(1): 5-7.
14. Tesmer LA, Lundy SK, Sarkar S, Fox DA. Th17 cells in human disease. Immunol Rev 2008; 223: 87-113.
15. Dubin PJ, Kolls JK.Th17 cytokines andmucosal immunity. Immunol Rev 2008; 226: 160-171.
16. Fouser LA,Wright JF, Dunussi-Joannopoulos K, Collins M. Th17 cytokines and their emerging roles in inflammation and autoimmunity. Immunol Rev 2008; 226: 87-102.
17. Hu H,Djuretic I, Sundrud MS, Rao A. Transcriptional partners in regulatory T cells: Foxp3, Runx and NFAT. Trends Immunol 2007; 28(8): 329-332.
18. Lonard DM, O'Malley BW. Nuclear receptor coregulators: Modulators of pathology and therapeutic targets. Nat Rev Endocrinol 2012; 8(10): 598-604.
19. Rudra D, deRoos P, Chaudhry A, et al. Transcription factor Foxp3 and its protein partners form a complex regulatory network. Nat Immunol 2012; 13(10): 1010-1019.
20. Li B, Samanta A, Song X, et al. FOXP3 ensembles in T-cell regulation. Immunol Rev 2006; 212: 99-113.
21. Zhang F, Meng G, Strober W. Interactions among the transcription factors Runx1, RORgammat and Foxp3 regulate the differentiation of interleukin 17-producing T cells. Nat Immunol 2008; 9(11): 1297-1306.
22. Pan F, Fan H, Lu L, et al. The yin and yang of signaling in Tregs and TH17 cells. Sci Signal 2011; 4(165): Mr4.
23. So AY, Zhao JL, BaltimoreD.The Yin and Yang ofmicroRNAs: Leukemia and immunity.Immunol Rev 2013; 253(1): 129-145.
24. Ouyang X, Zhang R, Yang J, et al. Transcription factor IRF8 directs a silencing programme for TH17 cell differentiation. Nat Commun. 2011; 2: 314.
25. Evans RM,Mangelsdorf DJ. Nuclear Receptors, RXR, and the Big Bang. Cell 2014; 157(1): 255-266.
26. Huh JR, LeungMW, Huang P, et al. Digoxin and its derivatives suppress TH17 cell differentiation by antagonizing RORgammat activity. Nature 2011; 472(7344): 486-490.
27. Fujita-Sato S, Ito S, Isobe T, et al. Structural basis of digoxin that antagonizes RORgamma t receptor activity and suppressesTh17 cell differentiation and interleukin (IL)-17 production. J Biol Chem 2011; 286(36): 31409-31417.
28. Xiao S, Yosef N, Yang J, et al. Small-molecule RORgammat antagonists inhibit T helper 17 cell transcriptional network by divergentmechanisms. Immunity 2014; 40(4): 477-489.
29. Solt LA, Kumar N, Nuhant P, et al. Suppression of TH17 differentiation and autoimmunity by a synthetic ROR ligand. Nature 2011; 472(7344): 491-494.
30. Xu T,Wang X, Zhong B, et al.Ursolic acid suppresses interleukin-17 (IL-17) production by selectively antagonizing the function of RORgamma t protein. J Biol Chem 2011; 286(26): 22707-22710.
31. Skepner J, Ramesh R, Trocha M, et al. Pharmacologic inhibition of RORgammat regulates Th17 signature gene expression and suppresses cutaneous inflammation in vivo. J Immunol 2014; 192(6): 2564-2575.
32. Martin B,Hirota K, Cua DJ, et al. Interleukin-17-producing gammadelta T cells selectively expand in response to pathogen products and environmental signals. Immunity 2009; 31(2): 321-330.
33. Cording S, Medvedovic J, Cherrier M, Eberl G. Development and regulation of RORgammat innate lymphoid cells. FEBS Lett 2014.
34. Spits H, Cupedo T. Innate lymphoid cells: Emerging insights in development, lineage relationships, and function. Annu Rev Immunol 2012; 30: 647-675.
35. Ichiyama K, Yoshida H, Wakabayashi Y, et al. Foxp3 inhibits RORgammat-mediated IL-17A mRNA transcription through direct interaction with RORgammat. J Biol Chem 2008; 283(25): 17003-17008.
36. Yang XO, Nurieva R, Martinez GJ, et al. Molecular antagonism and plasticity of regulatory and inflammatory T cell programs. Immunity 2008; 29(1): 44-56.
37. Zhou L, Lopes JE, Chong MM, et al. TGF-beta-induced Foxp3 inhibits T(H)17 cell differentiation by antagonizing RORgammat function. Nature 2008; 453(7192): 236-240.
38. Xiao S, Jin H, Korn T, et al. Retinoic acid increases Foxp3+ regulatory T cells and inhibits development of Th17 cells by enhancing TGF-beta-driven Smad3 signaling and inhibiting IL-6 and IL-23 receptor expression. J Immunol 2008; 181(4): 2277-2284.
39. Joshi S, Pantalena LC, Liu XK, et al. 1,25-dihydroxyvitamin D(3) amelioratesTh17 autoimmunity via transcriptionalmodulation of interleukin-17A.Mol Cell Biol 2011; 31(17): 3653-3669.
40. Lu L, Wang J, Zhang F, et al. Role of SMAD and non-SMAD signals in the development ofTh17 and regulatory T cells. J Immunol 2010; 184(8): 4295-4306.
41. Feng XH, Derynck R. Specificity and versatility in tgf-beta signaling through Smads. Annu Rev Cell Dev Biol 2005; 21: 659-693.
42. Wan YY, Flavell RA. 'Yin-Yang' functions of transforming growth factor-beta and T regulatory cells in immune regulation. Immunol Rev 2007; 220: 199-213.
43. Takimoto T, Wakabayashi Y, Sekiya T, et al. Smad2 and Smad3 are redundantly essential for the TGF-beta-mediated regulation of regulatory T plasticity and Th1 development. J Immunol 2010; 185(2): 842-855.
44. QinH,Wang L, Feng T, et al. TGF-beta promotesTh17cell development through inhibition of SOCS3. J Immunol 2009; 183(1): 97-105.
45. Martinez GJ, Zhang Z, Chung Y, et al. Smad3 differentially regulates the induction of regulatory and inflammatory T cell differentiation. J Biol Chem 2009; 284(51): 35283-35286.
46. Djuretic IM, Levanon D, Negreanu V, et al. Transcription factors T-bet and Runx3 cooperate to activate Ifng and silence Il4 in T helper type 1 cells. Nat Immunol 2007; 8(2): 145-153.
47. Cruz-Guilloty F, Pipkin ME, Djuretic IM, et al. Runx3 and T-box proteins cooperate to establish the transcriptional program of effector CTLs. J ExpMed 2009; 206(1): 51-59.
48. Coffman JA. Runx transcription factors and the developmental balance between cell proliferation and differentiation. Cell Biol Int 2003; 27(4): 315-324.
49. XieH, Sadim MS, Sun Z. RORgammat recruits steroid receptor coactivators to ensure thymocyte survival. J Immunol 2005; 175(6): 3800-3809.
50. Brustle A, Heink S, Huber M, et al. The development of inflammatory T(H)-17 cells requires interferon-regulatory factor 4. Nat Immunol 2007; 8(9): 958-966.
51. Malhotra N, Robertson E, Kang J. SMAD2 is essential for TGF beta-mediated Th17 cell generation. J Biol Chem 2010; 285(38): 29044-29048.
52. Martinez GJ, Zhang Z, Reynolds JM, et al. Smad2 positively regulates the generation of Th17 cells. J Biol Chem 2010; 285(38): 29039-29043.
53. Wagstaff KM, Jans DA. Importins and beyond: Non-conventional nuclear transport mechanisms. Traffic 2009; 10(9): 1188-1198.
54. Kurebayashi Y, Nagai S, Ikejiri A, et al. PI3K-Akt-mTORC1-S6K1/2 axis controlsTh17 differentiation by regulating Gfi1 expression and nuclear translocation of RORgamma. Cell Rep 2012; 1(4): 360-373.
55. Xu J, Li Q. Review of the in vivo functions of the p160 steroid receptor coactivator family. Mol Endocrinol 2003; 17(9): 1681-1692.
56. Lee Jacob S, Cua Daniel J.The emerging landscape of ROR? t biology. Immunity 2014; 40(4): 451-452.
57. Jetten AM. Retinoid-related orphan receptors (RORs): Critical roles in development, immunity, circadian rhythm, and cellularmetabolism. Nucl Recept Signal 2009; 7: E003.
58. Patel DD, Lee DM, Kolbinger F, Antoni C. Effect of IL-17A blockade with secukinumab in autoimmune diseases. Ann Rheum Dis 2013; 72(2): Ii116-ii123.
59. Sandborn WJ,GasinkC,Gao LL, et al. Ustekinumab induction andmaintenance therapy in refractory Crohn's disease. N Engl JMed 2012; 367(16): 1519-1528.
60. Yang XO, Pappu BP, Nurieva R, et al. T helper 17 lineage differentiation is programmed by orphan nuclear receptors ROR alpha and ROR gamma. Immunity 2008; 28(1): 29-39.
61. SchramlBU,HildnerK, Ise W, et al.TheAP-1 transcription factor Batf controls T(H)17 differentiation. Nature 2009; 460(7253): 405-409.
62. Bauquet AT, Jin H, Paterson AM, et al. The costimulatory molecule ICOS regulates the expression of c-Maf and IL-21 in the development of follicular T helper cells and TH-17 cells. Nat Immunol 2009; 10(2): 167-175.
63. Veldhoen M, Hirota K, Westendorf AM, et al. The aryl hydrocarbon receptor links TH17-cellmediated autoimmunity to environmental toxins. Nature 2008; 453(7191): 106-109.
64. Okamoto K, Iwai Y, Oh-Hora M, et al. IkappaBzeta regulates T(H)17 development by cooperating with ROR nuclear receptors. Nature 2010; 464(7293): 1381-1385.
65. Chen Z, Laurence A, Kanno Y, et al. Selective regulatory function of Socs3 in the formation of IL-17- secreting T cells. Proc Natl Acad Sci U S A 2006; 103(21): 8137-8142.
66. Yang XO, Panopoulos AD,Nurieva R, et al. STAT3 regulates cytokine-mediated generation of inflammatory helper T cells. J Biol Chem 2007; 282(13): 9358-9363.
67. Li P, Spolski R, Liao W, et al. BATF-JUN is critical for IRF4-mediated transcription in T cells. Nature 2012; 490(7421): 543-546.
68. Oestreich KJ, Weinmann AS. Master regulators or lineage-specifying? Changing views on CD4+ T cell transcription factors. Nat Rev Immunol 2012; 12(11): 799-804.
69. Hwang ES, Szabo SJ, Schwartzberg PL, Glimcher LH. T helper cell fate specified by kinase-mediated interaction of T-bet with GATA-3. Science 2005; 307(5708): 430-433.
70. Eberl G,Marmon S, SunshineMJ, et al. An essential function for the nuclear receptor RORgamma(t) in the generation of fetal lymphoid tissue inducer cells. Nat Immunol 2004; 5(1): 64-73.
71. Eberl G, Littman DR. Thymic origin of intestinal alphabeta T cells revealed by fate mapping of RORgammat+ cells. Science 2004; 305(5681): 248-251.